Emergent BioSolutions Inc (NYSE: EBS) stock closed at $6.15 on 3/12/25 after a major increase of 11.2%. Moreover, trading volume in this advance was above average at 128% of normal. The stock has declined -3.8% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Emergent BioSolutions has a current Value Trend Rating of C (High Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Emergent BioSolutions has a good Appreciation Score of 77 but a neutral Power Rating of 43, triggering the High Neutral Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment